Elixinol Wellness Limited
ELLXF
$0.01
$0.01248.78%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 10.25M | 10.04M | 9.87M | 8.77M | 7.60M |
| Total Other Revenue | 14.60K | 7.20K | -- | -- | -- |
| Total Revenue | 10.27M | 10.04M | 9.87M | 8.77M | 7.60M |
| Cost of Revenue | 6.64M | 6.50M | 6.38M | 5.68M | 4.94M |
| Gross Profit | 3.62M | 3.55M | 3.48M | 3.08M | 2.66M |
| SG&A Expenses | 6.12M | 5.95M | 5.82M | 5.82M | 5.78M |
| Depreciation & Amortization | 657.70K | 670.90K | 687.20K | 631.20K | 571.00K |
| Other Operating Expenses | 495.30K | 425.40K | 357.80K | 152.20K | -57.50K |
| Total Operating Expenses | 13.91M | 13.55M | 13.25M | 12.29M | 11.24M |
| Operating Income | -3.65M | -3.50M | -3.38M | -3.52M | -3.63M |
| Income Before Tax | -3.65M | -3.57M | -3.50M | -4.01M | -4.50M |
| Income Tax Expenses | -2.37M | -2.37M | -2.37M | -1.20M | 1.20K |
| Earnings from Continuing Operations | -1.28 | -1.19 | -1.13 | -2.81 | -4.50 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -1.28M | -1.19M | -1.13M | -2.81M | -4.50M |
| EBIT | -3.65M | -3.50M | -3.38M | -3.52M | -3.63M |
| EBITDA | -3.23M | -3.03M | -2.85M | -3.04M | -3.23M |
| EPS Basic | -0.01 | -0.01 | -0.01 | -0.03 | -0.05 |
| Normalized Basic EPS | -0.01 | -0.01 | -0.01 | -0.02 | -0.02 |
| EPS Diluted | -0.01 | -0.01 | -0.01 | -0.03 | -0.05 |
| Normalized Diluted EPS | -0.01 | -0.01 | -0.01 | -0.02 | -0.02 |
| Average Basic Shares Outstanding | 813.04M | 715.63M | 618.21M | 507.30M | 396.38M |
| Average Diluted Shares Outstanding | 813.04M | 715.63M | 618.21M | 507.30M | 396.38M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |